The ACC's Clinical Trials Research (CTR): Upping Your Game Program is a year-long professional development opportunity for cardiologists, cardiac surgeons and doctorate–level trained cardiovascular ...

In this week’s View, Dr. Eagle highlights several important studies presented at the recent American Heart Association Scientific Sessions. The OCEAN Trial on antithrombotic and stroke prevention in ...

In this episode, Keith C. Ferdinand, MD, FACC, discusses why low blood pressure (BP) should not delay heart failure (HF) treatment.

ACC's October Board of Trustees (BOT) meeting was rich with strategic dialogue and forward-looking initiatives that reflect our shared commitment to advancing cardiovascular care and strengthening the ...

Fewer than half of young adults with severely high low-density lipoprotein (LDL-C), or “bad” cholesterol, levels start taking a statin within five years of first high LDL-C measurement, according to a ...

A new multi-society Advanced Training Statement on Advanced Cardiovascular Imaging addresses the core competencies and training requirements necessary for advanced cardiovascular imagers across all ...

Work, practice, expense and liability relative value units (RVUs) are updated annually through Medicare Physician Fee Schedule rulemaking. In response to the recently released 2026 Medicare PFS final ...

Renew your commitment to a community centered around you. Join us as we work to overcome the challenges of today and work toward a better tomorrow. Enroll in auto-renewal of your ACC membership when ...

Patients with atrial fibrillation (AFib) who drank an average of one cup of coffee a day following successful cardioversion had fewer recurrences of AFib or atrial flutter compared with those who ...

This page features ACC's full coverage of the latest science from American Heart Association's (AHA) Scientific Sessions 2025, taking place Nov. 7–10 in New Orleans, LA.